These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2804692)

  • 1. Lamina-selective A68 immunoreactivity in primary visual cortex of Alzheimer's disease patients.
    Beach TG; Walker R; McGeer EG
    Brain Res; 1989 Oct; 501(1):171-4. PubMed ID: 2804692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senile plaques, amyloid beta-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex.
    Beach TG; McGeer EG
    Acta Neuropathol; 1992; 83(3):292-9. PubMed ID: 1373024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.
    Hof PR; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):55-64. PubMed ID: 1706358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex.
    Beach TG; McGeer EG
    Brain Res; 1988 Nov; 463(2):357-61. PubMed ID: 3196922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
    Brady DR; Mufson EJ
    J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat.
    Byne W; Mattiace L; Kress Y; Davies P
    J Comp Neurol; 1991 Apr; 306(4):602-12. PubMed ID: 2071697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology.
    Einstein G; Patel V; Bautista P; Kenna M; Melone L; Fader R; Karson K; Mann S; Saunders AM; Hulette C; Mash D; Roses AD; Schmechel DE
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1190-201. PubMed ID: 9862642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients.
    van de Nes JA; Kamphorst W; Ravid R; Swaab DF
    Brain; 1993 Feb; 116 ( Pt 1)():103-15. PubMed ID: 7680932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue.
    de la Monte SM; Spratt RA; Chong J; Ghanbari HA; Wands JR
    Am J Pathol; 1992 Dec; 141(6):1459-69. PubMed ID: 1466403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of A68 levels in Alzheimer diseased and non-Alzheimer's diseased brain by two ALZ50 based methods.
    Miller BE
    Life Sci; 1999; 65(21):2215-22. PubMed ID: 10576593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidergic neurons of subcortical white matter in aging and Alzheimer's brain.
    Ang LC; Shul DD
    Brain Res; 1995 Mar; 674(2):329-35. PubMed ID: 7540926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology.
    Anderson AJ; Cummings BJ; Cotman CW
    Exp Neurol; 1994 Feb; 125(2):286-95. PubMed ID: 8313943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic fiber loss occurs in the absence of synaptophysin depletion in Alzheimer's disease primary visual cortex.
    Beach TG; McGeer EG
    Neurosci Lett; 1992 Aug; 142(2):253-6. PubMed ID: 1454223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis.
    Kumar U
    Neuroscience; 2005; 134(2):525-38. PubMed ID: 15961235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.
    Love S; Saitoh T; Quijada S; Cole GM; Terry RD
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):393-405. PubMed ID: 2838588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease.
    Swaab DF; Grundke-Iqbal I; Iqbal K; Kremer HP; Ravid R; van de Nes JA
    Brain Res; 1992 Sep; 590(1-2):239-49. PubMed ID: 1330213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease.
    Doebler JA; Markesbery WR; Anthony A; Davies P; Scheff SW; Rhoads RE
    Ann Neurol; 1988 Jan; 23(1):20-4. PubMed ID: 2449843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.